Xiamen C&D Balance Sheet Health
Financial Health criteria checks 5/6
Xiamen C&D has a total shareholder equity of CN¥228.1B and total debt of CN¥163.1B, which brings its debt-to-equity ratio to 71.5%. Its total assets and total liabilities are CN¥876.0B and CN¥647.9B respectively. Xiamen C&D's EBIT is CN¥13.5B making its interest coverage ratio 6.7. It has cash and short-term investments of CN¥93.3B.
Key information
71.5%
Debt to equity ratio
CN¥163.13b
Debt
Interest coverage ratio | 6.7x |
Cash | CN¥93.30b |
Equity | CN¥228.15b |
Total liabilities | CN¥647.86b |
Total assets | CN¥876.01b |
Recent financial health updates
Recent updates
Xiamen C&D's (SHSE:600153) Problems Go Beyond Weak Profit
Nov 06Xiamen C&D Inc.'s (SHSE:600153) Price Is Right But Growth Is Lacking After Shares Rocket 33%
Sep 27A Look At The Fair Value Of Xiamen C&D Inc. (SHSE:600153)
Aug 22Xiamen C&D (SHSE:600153) Takes On Some Risk With Its Use Of Debt
Jul 23Xiamen C&D Inc.'s (SHSE:600153) Business And Shares Still Trailing The Market
May 27Xiamen C&D's (SHSE:600153) Solid Earnings May Rest On Weak Foundations
Apr 25Analysts Just Slashed Their Xiamen C&D Inc. (SHSE:600153) EPS Numbers
Apr 21Xiamen C&D Inc. Just Beat EPS By 17%: Here's What Analysts Think Will Happen Next
Apr 19Financial Position Analysis
Short Term Liabilities: 600153's short term assets (CN¥683.0B) exceed its short term liabilities (CN¥507.0B).
Long Term Liabilities: 600153's short term assets (CN¥683.0B) exceed its long term liabilities (CN¥140.9B).
Debt to Equity History and Analysis
Debt Level: 600153's net debt to equity ratio (30.6%) is considered satisfactory.
Reducing Debt: 600153's debt to equity ratio has reduced from 161.4% to 71.5% over the past 5 years.
Debt Coverage: 600153's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 600153's interest payments on its debt are well covered by EBIT (6.7x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/09 09:27 |
End of Day Share Price | 2025/01/09 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Xiamen C&D Inc. is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Tian ShiXin | BOCI Research Ltd. |
Eric Du | BofA Global Research |
Xin Yang | China International Capital Corporation Limited |